What is Us Pharmatech?
US Pharmatech Inc. operates as a prominent manufacturer of dietary supplements, offering comprehensive OEM and private label services. The company provides end-to-end solutions encompassing product creation, packaging, labeling, and shipping. With an extensive portfolio of over 10,000 existing formulas and a robust research and development division that has pioneered more than 40,000 unique formulations, US Pharmatech caters to a diverse clientele seeking high-quality nutraceutical and supplement manufacturing. Their expertise spans both solid and liquid product forms, positioning them as a key partner for businesses aiming to bring innovative supplement products to market.
How much funding has Us Pharmatech raised?
Us Pharmatech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Us Pharmatech?
The context of 'large-scale late-stage funding' and a 'major strategic investment' suggests Us Pharmatech is poised for significant scaling and market penetration. This infusion of capital is likely earmarked for expanding manufacturing capabilities, enhancing research and development efforts, and potentially broadening distribution channels. The strategic nature of the recent backing indicates a focus on solidifying market leadership and potentially exploring new product categories or technological advancements within the nutraceutical and dietary supplement industry. This phase of growth is critical for leveraging their extensive formula library and manufacturing prowess to capture a larger share of the global market.
See full Us Pharmatech company page
